Pedro Pablo Gonzalez Perez

Dr. Pedro Pablo Gonzalez Perez

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2022 in Entropy
Verified
Journal Article
Open access
PDF file
MSMáximo Eduardo Sánchez-Gutiérrez
Máximo Eduardo Sánchez-Gutiérrez
PPPedro Pablo Gonzalez Perez
Pedro Pablo Gonzalez Perez
Medical data includes clinical trials and clinical data such as patient-generated health data, laboratory results, medical imaging, and different signals coming from continuous health monitoring. Some commonly used data analysis techniques are text mining, big data analytics, and data mining. These techniques can be used for classification, clustering, and machine learning tasks. Machine learning could be described as an automatic learning process derived from concepts and knowledge without deliberate system coding. However, finding a suitable machine learning architecture for a specific task is still an open problem. In this work, we propose a machine learning model for the multi-class classification of medical data. This model is comprised of two components—a restricted Boltzmann machine and a classifier system. It uses a discriminant pruning method to select the most salient neurons in the hidden layer of the neural network, which implicitly leads to a selection of features for the input patterns that feed the classifier system. This study aims to investigate whether information-entropy measures may provide evidence for guiding discriminative pruning in a neural network for medical data processing, particularly cancer research, by using three cancer databases: Breast Cancer, Cervical Cancer, and Primary Tumour. Our proposal aimed to investigate the post-training neuronal pruning methodology using dissimilarity measures inspired by the information-entropy theory; the results obtained after pruning the neural network were favourable. Specifically, for the Breast Cancer dataset, the reported results indicate a 10.68% error rate, while our error rates range from 10% to 15%; for the Cervical Cancer dataset, the reported best error rate is 31%, while our proposal error rates are in the range of 4% to 6%; lastly, for the Primary Tumour dataset, the reported error rate is 20.35%, and our best error rate is 31%.

1 January 2023 in Journal of Algorithms & Computational Technology
Verified
Journal Article
Open access
MSMáximo E Sánchez-Gutiérrez
Máximo E Sánchez-Gutiérrez
PPPedro Pablo Gonzalez Perez
Pedro Pablo Gonzalez Perez
One common issue with datasets used for supervised classification tasks is data imbalance or the unequal distribution of classes within a dataset. The class imbalance may cause biased machine learning models to favor the dominant class, misclassifying the minority class. Specific techniques can be employed to deal with the issue of class imbalance, including resampling by oversampling or undersampling and ensemble approaches. Besides, generative adversarial networks, a deep learning technique for building generative models, offer an alternative machine learning technique that is particularly well suited to address the class imbalance problem. This work introduces a machine learning-based approach to deal with the class imbalance in a cancer intracellular signaling dataset produced by a verified and validated computer simulation. Specifically, we use synthetic data generation to increase and balance the dataset generated by the computational simulation. The used approach simulates the oversampling method by employing a generative adversarial network to produce new examples for the minority class. Subsequently, we applied supervised machine learning methods, such as the K-NN algorithm, to assess whether or not the classification accuracy improved relative to the unbalanced dataset. The results presented in this work have shown an accuracy increase in the classification of patterns belonging to the minority class, with an improvement of [ ].

1 January 2022 in Cancer Informatics
Verified
Journal Article
Open access
AOAlejandra Ortiz-González
Alejandra Ortiz-González
PPPedro Pablo Gonzalez Perez
Pedro Pablo Gonzalez Perez
MCMaura Cárdenas-García
Maura Cárdenas-García
MHMaría Guadalupe Hernández-Linares
María Guadalupe Hernández-Linares
The search for new cancer treatments from traditional medicine involves developing studies to understand at the molecular level different cell signaling pathways involved in cancer development. In this work, we present a model of the PI3K/Akt/mTOR pathway, which plays a key role in cell cycle regulation and is related to cell survival, proliferation, and growth in cancer, as well as resistance to antitumor therapies, so finding drugs that act on this pathway is ideal to propose a new adjuvant treatment. The aim of this work was to model, simulate and predict in silico using the Big Data-Cellulat platform the possible targets in the PI3K/Akt/mTOR pathway on which the Opuntia joconostle extract acts, as well as to indicate the concentration range to be used to find the mean lethal dose in in vitro experiments on breast cancer cells. The in silico results show that, in a cancer cell, the activation of JAK and STAT, as well as PI3K and Akt is related to the effect of cell proliferation, angiogenesis, and inhibition of apoptosis, and that the extract of O. joconostle has an antiproliferative effect on breast cancer cells by inhibiting cell proliferation, regulating the cell cycle and inhibiting apoptosis through this signaling pathway . In vitro it was demonstrated that the extract shows an antiproliferative effect, causing the arrest of cells in the G2/M phase of the cell cycle. Therefore, it is concluded that the use of in silico tools is a valuable method to perform virtual experiments and discover new treatments. The use of this type of model supports in vitro experimentation, reducing the costs and number of experiments in the real laboratory.

1 January 2022 in Bioinformatics and Biology Insights
Verified
Journal Article
Open access
MSMáximo Eduardo Sánchez-Gutiérrez
Máximo Eduardo Sánchez-Gutiérrez
PPPedro Pablo Gonzalez Perez
Pedro Pablo Gonzalez Perez
This work explores how much the traditional approach to modeling and simulation of biological systems, specifically cell signaling networks, can be increased and improved by integrating big data, data mining, and machine learning techniques. Specifically, we first model, simulate, validate, and calibrate the behavior of the PI3K/AKT/mTOR cancer-related signaling pathway. Subsequently, once the behavior of the simulated signaling network matches the expected behavior, the capacity of the computational simulation is increased to grow data (data farming). First, we use big data techniques to extract, collect, filter, and store large volumes of data describing all the interactions among the simulated cell signaling system components over time. Afterward, we apply data mining and machine learning techniques—specifically, exploratory data analysis, feature selection techniques, and supervised neural network models—to the resulting biological dataset to obtain new inferences and knowledge about this biological system. The results showed how the traditional approach to the simulation of biological systems could be enhanced and improved by incorporating big data, data mining, and machine learning techniques, which significantly contributed to increasing the predictive power of the simulation.

1 January 2016 in Bioinformatics and Biology Insights
Verified
Journal Article
Open access
MCMaura Cárdenas-García
Maura Cárdenas-García
PPPedro Pablo Gonzalez Perez
Pedro Pablo Gonzalez Perez
Sara MontagnaSara Montagna
Sara Montagna
OCOscar Sánchez Cortés
Oscar Sánchez Cortés
MHMarta Elena Hernandez-Caballero
Marta Elena Hernandez-Caballero
Intercellular communication is very important for cell development and allows a group of cells to survive as a population. Cancer cells have a similar behavior,...

1 April 2016 in BioSystems
Verified
Journal Article
Closed access
SASalomón de Jesús Alas
Salomón de Jesús Alas
PPPedro Pablo Gonzalez Perez
Pedro Pablo Gonzalez Perez